US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

iShares U.S. Tech Breakthrough Multisector ETF

80.59

+1.261.59%

Post-market: 80.58-0.0100-0.01%19:30 EDT

Volume:9K

Turnover:685.51K

Market Cap:527.86M

PE:- -

High:80.59

Open:79.67

Low:79.67

Close:79.33

52wk High:80.62

52wk Low:53.33

Shares:6.55M

Float Shares:6.55M

Volume Ratio:0.87

T/O Rate:0.13%

Dividend:0.22

Dividend Rate:0.27%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Teva announces FDA approval for Weltruza

How to prevent the next Asos? Give businesses cybersecurity tax relief

Novartis announces FDA approval of Rhapsido for symptomatic dermographism

Novartis Rhapsido® (remibrutinib) receives FDA approval as first treatment for symptomatic dermographism (SD), expanding its use beyond chronic spontaneous urticaria (CSU)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/TECB"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"TECB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TECB\",,,,,undefined,":{"symbol":"TECB","market":"US","secType":"STK","nameCN":"iShares U.S. Tech Breakthrough Multisector ETF","latestPrice":80.59,"timestamp":1791576000000,"preClose":79.3321,"halted":0,"volume":8545,"hourTrading":{"tag":"盘后","latestPrice":80.58,"preClose":80.59,"latestTime":"19:30 EDT","volume":9,"amount":725.25996,"timestamp":1791588606648,"change":-0.01,"changeRate":-0.000124,"amplitude":0},"delay":0,"changeRate":0.015856128855784815,"floatShares":6550000,"shares":6550000,"eps":0,"marketStatus":"Post-Mkt","change":1.2579,"latestTime":"10-09 19:47:53 EDT","open":79.67,"high":80.59,"low":79.67,"amount":685511.94375,"amplitude":0.011597,"askPrice":80.58,"askSize":7,"bidPrice":73.04,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1791590400000},"marketStatusCode":4,"adr":0,"exchange":"ARCA","adjPreClose":79.3321,"sharesOutstanding":7200000,"nav":79.911822,"aum":523422434.1,"dividendRate":0.002677,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":79.3321,"preClose":79.3321,"latestTime":"07:38 EDT","volume":1,"amount":79.3321,"timestamp":1791545933467,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":80.58,"preClose":80.59,"latestTime":"19:30 EDT","volume":9,"amount":725.25996,"timestamp":1791588606648,"change":-0.01,"changeRate":-0.000124,"amplitude":0},"volumeRatio":0.869101,"impliedVol":0.1169,"impliedVolPercentile":0.4382},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TECB\",,,,,undefined,":{"symbol":"TECB","floatShares":6550000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.869101,"shares":6550000,"dividePrice":0.2157,"high":80.59,"amplitude":0.011597,"preClose":79.3321,"low":79.67,"week52Low":53.33,"pbRate":"--","week52High":80.615,"institutionHeld":0,"latestPrice":80.59,"committee":0.869159,"eps":0,"divideRate":0.002677,"volume":8545,"delay":0,"ttmEps":0,"open":79.67,"prevYearClose":60.88,"prevWeekClose":79.36,"prevMonthClose":78.93,"prevQuarterClose":78.93,"fiveDayClose":79.36,"twentyDayClose":75.4129,"sixtyDayClose":71.05},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TECB\",params:#limit:5,,,undefined,":[{"date":"2026-09-15","symbol":"TECB","amount":0.052739,"announcedDate":"2026-09-14","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-15","defaultRemindTime":1789479000000,"name":"iShares U.S. Tech Breakthrough Multisector ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-18","payableDate":"2026-09-15","currency":"USD","dateTimestamp":1789444800000,"payDate":"2026-09-18"},{"date":"2026-06-15","symbol":"TECB","amount":0.053655,"announcedDate":"2026-06-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"iShares U.S. Tech Breakthrough Multisector ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2026-03-17","symbol":"TECB","amount":0.036608,"announcedDate":"2026-03-16","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-17","defaultRemindTime":1773754200000,"name":"iShares U.S. Tech Breakthrough Multisector ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-20","payableDate":"2026-03-17","currency":"USD","dateTimestamp":1773720000000,"payDate":"2026-03-20"},{"date":"2025-12-16","symbol":"TECB","amount":0.073419,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"iShares U.S. Tech Breakthrough Multisector ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2025-09-16","symbol":"TECB","amount":0.050565,"announcedDate":"2025-09-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-16","defaultRemindTime":1758029400000,"name":"iShares U.S. Tech Breakthrough Multisector ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-19","payableDate":"2025-09-16","currency":"USD","dateTimestamp":1757995200000,"payDate":"2025-09-19"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TECB\",market:\"US\",,,undefined,":[{"executeDate":"2020-03-25","recordDate":"2020-03-26","paymentDate":"2020-03-31","value":0.141825,"currency":"USD"},{"executeDate":"2020-06-15","recordDate":"2020-06-16","paymentDate":"2020-06-19","value":0.017274,"currency":"USD"},{"executeDate":"2020-09-23","recordDate":"2020-09-24","paymentDate":"2020-09-29","value":0.042931,"currency":"USD"},{"executeDate":"2020-12-14","recordDate":"2020-12-15","paymentDate":"2020-12-18","value":0.028868,"currency":"USD"},{"executeDate":"2021-03-25","recordDate":"2021-03-26","paymentDate":"2021-03-31","value":0.041361,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TECB\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TECB\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2674785642","title":"Teva announces FDA approval for Weltruza","url":"https://stock-news.laohu8.com/highlight/detail?id=2674785642","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674785642?lang=en_us&edition=fundamental","pubTime":"2026-10-09 19:05","pubTimestamp":1791543924,"startTime":"0","endTime":"0","summary":"Teva (TEVA) announced that the FDA has approved Weltruza for extended-release injectable suspension, a new, once-monthly, subcutaneous long-acting ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/teva-announces-fda-approval-for-weltruza-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/teva-announces-fda-approval-for-weltruza-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSCH","LFSC","TEVA","MRNY","GDOC","BK4588","BK4566","BK4007","IYH","XLVX","BBP","BK4596","IDNA","MEDI","TECB","BMED","LABU","NVIB","BK4557","IBB","LU2324357040.USD","FRTY","BK4584","IEIH","SYNB","GNMX","TBXU","RSPH","LU1983299246.USD","PINK","BK4559","BK4585","MRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674388705","title":"How to prevent the next Asos? Give businesses cybersecurity tax relief","url":"https://stock-news.laohu8.com/highlight/detail?id=2674388705","media":"cityam","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674388705?lang=en_us&edition=fundamental","pubTime":"2026-10-09 11:31","pubTimestamp":1791516660,"startTime":"0","endTime":"0","summary":"With Asos just the latest big British retailer to be the victim of a cyber hack, it’s time for the government to start incentivising businesses to up their security, writes Matt WarmanOn Tuesday, Asos customers across the UK were sent pop-up messages from its app that appeared to be from hackers.The clothing giant will need time to figure out exactly what happened, but shoppers getting concerning messages through an app they trust will worry businesses, markets and our government.Stay ahead with our three daily briefings delivering all the key market moves, top business and political stories, and incisive analysis straight to your inbox.When it comes to cybersecurity, there are three key things the government can do in the Budget which would genuinely make a difference.","market":"us","thumbnail":"https://www.cityam.com/wp-content/uploads/2026/10/Asos-hangers-e1791474035650.jpg?w=824&h=463&crop=1","type":0,"news_type":0,"thumbnails":["https://www.cityam.com/wp-content/uploads/2026/10/Asos-hangers-e1791474035650.jpg?w=824&h=463&crop=1"],"rights":{"source":"cityam_highlight","url":"https://www.cityam.com/how-to-prevent-the-next-asos-give-businesses-cybersecurity-tax-relief/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.cityam.com/how-to-prevent-the-next-asos-give-businesses-cybersecurity-tax-relief/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"cityam_highlight","symbols":["XT","DARP","FITE","DYNI","KOMP","UCYB","LOUP","TEK","NBDS","SPAM","FIGO","FWD","TECB","PSWD","BKIV","MVPS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673011517","title":"Novartis announces FDA approval of Rhapsido for symptomatic dermographism","url":"https://stock-news.laohu8.com/highlight/detail?id=2673011517","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673011517?lang=en_us&edition=fundamental","pubTime":"2026-10-07 23:50","pubTimestamp":1791388212,"startTime":"0","endTime":"0","summary":"Novartis (NVS) announced that the Food and Drug Administration approved Rhapsido as the first treatment for adults with symptomatic dermographism i...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/novartis-announces-fda-approval-of-rhapsido-for-symptomatic-dermographism-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/novartis-announces-fda-approval-of-rhapsido-for-symptomatic-dermographism-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSCH","MEDX","LU0070302665.USD","XLVX","NVIB","LU0208291251.USD","IE00BJT1NW94.SGD","BMED","LFSC","IYH","LABU","FRTY","BK4585","BK4588","BBP","BK4007","MEDI","IEIH","TECB","GNMX","PINK","BK4578","MRNY","LU0320765489.SGD","IE0002141913.USD","IBB","SYNB","TBXU","GDOC","IDNA","BK4532","MRNX","IE00BFTCPJ56.SGD","IE0009355771.USD","IE00B4R5TH58.HKD","LU0211331839.USD","RSPH","NVS","IE00BJJMRZ35.SGD","PPH","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673118620","title":"Novartis Rhapsido® (remibrutinib) receives FDA approval as first treatment for symptomatic dermographism (SD), expanding its use beyond chronic spontaneous urticaria (CSU)","url":"https://stock-news.laohu8.com/highlight/detail?id=2673118620","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673118620?lang=en_us&edition=fundamental","pubTime":"2026-10-07 23:45","pubTimestamp":1791387900,"startTime":"0","endTime":"0","summary":"In Phase III RemIND trial, twice as many adults taking Rhapsido achieved complete hive resolution by Week 12 vs placebo, with responses seen by Week 21SD is most prevalent type of chronic inducible ur","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/07/3376686/0/en/novartis-rhapsido-remibrutinib-receives-fda-approval-as-first-treatment-for-symptomatic-dermographism-sd-expanding-its-use-beyond-chronic-spontaneous-urticaria-csu.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IAI","LU1064131342.USD","LU1720051108.HKD","LU0210528500.USD","LU1668664300.SGD","LU0528227936.USD","LU0267386448.USD","MEDI","PINK","LU2089284900.SGD","PSCH","KBWB","LU2357305700.SGD","LU2487616109.SGD","SD","TBXU","TECB","BK4581","LFSC","MRNX","LABU","BK4585","LU1720051017.SGD","LU0390134368.USD","NVIB","FRTY","IBB","BK4504","LU0912757837.SGD","BBP","LU1791710582.SGD","IEIH","LU2028103732.USD","BMED","MRNY","XLVX","LU1244550221.USD","LU0795875169.SGD","SYNB","RSPH","LU2023251221.USD","GDOC","LU2264538146.SGD","IE00BZ1G4Q59.USD","LU0106831901.USD","IE00B3S45H60.SGD","LU1989772840.SGD","IYH","GNMX","IDNA"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":49,"pageCount":1,"totalSize":196,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/TECB\",params:#limit:6,delay:false,,,undefined,":[]}}